US20220151675A1 - Medical devices utilizing shape memory alloys and associated systems and methods - Google Patents
Medical devices utilizing shape memory alloys and associated systems and methods Download PDFInfo
- Publication number
- US20220151675A1 US20220151675A1 US17/650,232 US202217650232A US2022151675A1 US 20220151675 A1 US20220151675 A1 US 20220151675A1 US 202217650232 A US202217650232 A US 202217650232A US 2022151675 A1 US2022151675 A1 US 2022151675A1
- Authority
- US
- United States
- Prior art keywords
- treatment element
- lumen
- state
- energy source
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229910001285 shape-memory alloy Inorganic materials 0.000 title claims abstract description 13
- 238000000034 method Methods 0.000 title abstract description 22
- 229910000734 martensite Inorganic materials 0.000 claims abstract description 44
- 239000012530 fluid Substances 0.000 claims description 13
- 201000010260 leiomyoma Diseases 0.000 claims description 7
- 210000004696 endometrium Anatomy 0.000 claims description 6
- 206010028980 Neoplasm Diseases 0.000 claims description 4
- 238000005516 engineering process Methods 0.000 abstract description 41
- 210000001519 tissue Anatomy 0.000 description 31
- 229920000147 Styrene maleic anhydride Polymers 0.000 description 19
- 239000000463 material Substances 0.000 description 10
- 238000005520 cutting process Methods 0.000 description 9
- 229910001000 nickel titanium Inorganic materials 0.000 description 7
- 239000000523 sample Substances 0.000 description 6
- 229910001566 austenite Inorganic materials 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 210000000078 claw Anatomy 0.000 description 5
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 5
- 238000002679 ablation Methods 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- 230000001131 transforming effect Effects 0.000 description 4
- 230000007704 transition Effects 0.000 description 4
- 229910045601 alloy Inorganic materials 0.000 description 3
- 239000000956 alloy Substances 0.000 description 3
- 238000001574 biopsy Methods 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 230000003073 embolic effect Effects 0.000 description 3
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 230000001732 thrombotic effect Effects 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- 208000005189 Embolism Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 229910002836 PtFe Inorganic materials 0.000 description 2
- 230000000923 atherogenic effect Effects 0.000 description 2
- 230000002308 calcification Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- -1 copper-zinc-aluminum Chemical compound 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000005291 magnetic effect Effects 0.000 description 2
- 230000000926 neurological effect Effects 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 210000002307 prostate Anatomy 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000000626 ureter Anatomy 0.000 description 2
- 210000003708 urethra Anatomy 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010061692 Benign muscle neoplasm Diseases 0.000 description 1
- 241001631457 Cannula Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 201000004458 Myoma Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- JAWMENYCRQKKJY-UHFFFAOYSA-N [3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-ylmethyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-en-8-yl]-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]methanone Chemical compound N1N=NC=2CN(CCC=21)CC1=NOC2(C1)CCN(CC2)C(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F JAWMENYCRQKKJY-UHFFFAOYSA-N 0.000 description 1
- CMHKGULXIWIGBU-UHFFFAOYSA-N [Fe].[Pt] Chemical compound [Fe].[Pt] CMHKGULXIWIGBU-UHFFFAOYSA-N 0.000 description 1
- HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 description 1
- KGXDGSMJNUPTEQ-UHFFFAOYSA-N [Ti].[Ni].[Pt] Chemical compound [Ti].[Ni].[Pt] KGXDGSMJNUPTEQ-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000001994 activation Methods 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 210000003709 heart valve Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000002357 laparoscopic surgery Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 229910001092 metal group alloy Inorganic materials 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 238000007725 thermal activation Methods 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 206010047302 ventricular tachycardia Diseases 0.000 description 1
- 230000005186 women's health Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1482—Probes or electrodes therefor having a long rigid shaft for accessing the inner body transcutaneously in minimal invasive surgery, e.g. laparoscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/02—Inorganic materials
- A61L31/022—Metals or alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00059—Material properties
- A61B2018/00089—Thermal conductivity
- A61B2018/00095—Thermal conductivity high, i.e. heat conducting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00482—Digestive system
- A61B2018/00488—Esophagus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00482—Digestive system
- A61B2018/00494—Stomach, intestines or bowel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00559—Female reproductive organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00601—Cutting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1405—Electrodes having a specific shape
- A61B2018/1407—Loop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0014—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0042—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in shape-memory transition temperatures, e.g. in martensitic transition temperature, in austenitic transition temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/16—Materials with shape-memory or superelastic properties
Definitions
- the present technology is directed generally to medical devices utilizing shape memory alloys and associated systems and methods.
- SMA shape memory alloy
- a shape memory alloy is a metallic alloy that undergoes a phase transformation in its crystal structure when cooled from its stronger, high temperature form (austenite or parent) to its easily deformable, low temperature form (martensite or daughter). This inherent phase transformation is the basis for the unique properties of SMAs, such as shape memory and superelasticity.
- Shape memory refers to the ability of an SMA to go through the following process: (1) While in its martensitic form, the SMA is (easily) deformed to a new shape. (2) Upon being heated through its transformation temperatures, the SMA reverts to austenite and recovers its previous shape (before the deformation) with great force. The temperature at which the SMA remembers its austenite form when heated can be adjusted by slight changes in alloy composition and through heat treatment.
- Various medical device applications include an SMA component and utilize its shape memory properties to selectively transform the component between two different shapes or configurations. Such SMA components typically have an austenitic phase that is activated at a transition temperature typically at or below body temperature.
- Examples of such devices include dental wire, intravascular stents, guidewires, embolic coils, as well as staples, vertebral spacers, intrauterine devices, catheters, cannulas, and minimally invasive surgical instruments.
- Superelasticity is a mechanical version of shape memory, and is caused by the stress-induced formation of some martensite above its normal temperature. Because it has been formed above its normal temperature, the martensite reverts immediately to undeformed austenite as soon as the stress is removed. This process provides a very springy, “rubberlike” elasticity in these alloys.
- the superelastic properties of SMAs have been employed in various medical device applications where it is advantageous for the device to spring to form. Some examples of such devices include orthodontic wire, venous filters, vascular stents, and minimally invasive surgical instruments.
- FIG. 1A is a schematic, perspective view of a distal portion of a medical device showing a treatment element in an unconstrained austenitic state in accordance with the present technology.
- FIG. 1B is a schematic, perspective view of the treatment element shown in FIG. 1A bent back on itself in a low-profile martensitic state in a delivery sheath in accordance with the present technology.
- FIG. 1C is a schematic, perspective view of the treatment element shown in FIG. 1A in an elongated low-profile martensitic state in a delivery sheath in accordance with the present technology.
- FIG. 2A is a schematic, perspective view of a distal portion of a medical device showing a treatment element in an unconstrained austenitic state in accordance with the present technology.
- FIG. 2B is a schematic, perspective view of the treatment element shown in FIG. 1A bent back on itself in a low-profile martensitic state in a delivery sheath in accordance with the present technology.
- FIG. 2C is a schematic, perspective view of the treatment element shown in FIG. 1A in an elongated low-profile martensitic state in a delivery sheath in accordance with the present technology.
- FIGS. 3A-3C are side, top, and perspective views, respectively, of a treatment element in accordance with the present technology.
- FIGS. 3D-3F are side, top, and perspective views, respectively, of a treatment element in accordance with the present technology.
- FIGS. 3G-3I are side, top, and perspective views, respectively, of a treatment element in accordance with the present technology.
- FIGS. 3J-3L are side, top, and perspective views, respectively, of a treatment element in accordance with the present technology.
- FIGS. 4A and 4B are schematic illustrations of a treatment element in a deployed state and a constrained state in accordance with the present technology.
- FIG. 5A is a side view of a manipulation member having a looped treatment element at its distal portion in accordance with the present technology.
- FIGS. 5B-5D and FIGS. 6A-6C are side views and perspective side views, respectively, of treatment elements having different angles at their distal portions in the austenitic state in accordance with the present technology.
- FIG. 7A is a side view of a hysteroscopic resectoscope configured for use with the treatment elements of the present technology.
- FIG. 7B is an enlarged view of a distal portion of the hysteroscopic resectoscope shown in FIG. 7A .
- the treatment device includes a treatment element (e.g., an electrode or other device) configured to be delivered to a treatment site within a body cavity or lumen or other natural body orifice via a delivery device (e.g., a trocar, venipuncture, through a device lumen, etc.).
- a treatment element e.g., an electrode or other device
- the electrode is made of an SMA and is transformable between a delivery configuration and a deployed configuration via thermal activation. In the delivery configuration, the electrode is in its martensitic form and can be constrained for delivery through a delivery device and/or through narrow or tortuous bodily passages.
- the electrode is in an austenitic form that is configured to treat, manipulate, or otherwise engage bodily tissue at the treatment site.
- the shape and/or temperature of the electrode in the austenitic form can be configured for object retrieval, thrombus retrieval, tissue biopsy, tissue manipulation, and/or the atherectomy, morcellation, liquification, denaturation, des sication, fulgaration, cauterization, vaporization, cutting, and/or ablation of target tissue in minimally invasive and surgical applications.
- the electrode can be thermally activated to its austenitic form at a transition temperature above 40° C. (above body temperature).
- the electrode is coupled to an energy source, and activation of the austenitic phase of the electrode is achieved through use of heat energy and/or electrical current.
- Suitable energy sources include, for example, direct current (DC), alternating current (AC), radio frequency (RF), magnetic energy, electromagnetic energy, an electrical current transformed to mechanical energy via an ultrasonic transducer, thermal transfer (via fluidic heat exchange), and others.
- the electrode can be made of an SMA that is selected based on the desired physical characteristics and performance parameters of the particular device.
- SMAs include, for example, nickel titanium (“NiTi” or “nitinol”), platinum (“Pt”), platinum-titanium-nickel (“PtTiNi”), platinum iron (“PtFe”), copper-zinc-aluminum (“CuZnAl”), copper-aluminum-nickel (“CuAlNi”), and/or other alloys of/with platinum, nickel, iron, copper, titanium, etc.
- the treatment devices and/or electrodes of the present technology are configured for use in one or more medical applications and/or fields of medicine, such as gynecology, urology, cardiovascular, neurovascular, peripheral vascular, laparoscopy, pulmonology, ENT applications, and gastroenterology.
- medical applications and/or fields of medicine such as gynecology, urology, cardiovascular, neurovascular, peripheral vascular, laparoscopy, pulmonology, ENT applications, and gastroenterology.
- One embodiment of the present technology configured for gynecological applications includes a cutting electrode having a single or multiple loop configuration during use. At least a portion of the electrode can be formed of an SMA (such as NiTi or PtTiNi). Representative embodiments of the electrode and/or associated systems and methods are shown in FIGS. 1A-7B .
- the electrode is configured to be delivered in fluid medium to a uterine cavity through a lumen of a delivery device, such as the working channel of a hysteroscopic resectoscope ( FIGS. 7A and 7B ) or other delivery device having a lumen that is 8 mm or less. During delivery to the uterine cavity, the electrode can be compacted into a compressed martensitic shape to fit within the lumen of the delivery device.
- the electrode can be electrically connected to an energy source.
- the energy source can be electrode can be activated into the austenitic phase to form an expanded, pre-set shape (i.e., wider than the inner diameter of the delivery device lumen).
- the electrode can be activated via radiofrequency energy (RF) (e.g., from about 100 kHz to about 5 MHz).
- RF radiofrequency energy
- the electrode is configured to perform one or more procedures at the treatment site, such as cutting, ablating, resecting, manipulating, and/or cauterizing tissue such as leiomyoma, endometrium, or other tissue.
- the energy source can be de-activated or otherwise decoupled from the electrode such that the electrode temperature equilibrates (under fluid medium or ambient tissue temperature) to the martensitic phase.
- the device can be withdrawn from the uterine cavity through the delivery device.
- an ultrasonic surgical tip including an SMA (such as NiTi or PtTiNi).
- SMA such as NiTi or PtTiNi
- Representative embodiments of the electrode and/or associated systems and methods are shown in FIGS. 1-3 .
- the tip is configured to be introduced in a straight martensitic form through a lumen of a delivery device (such as the working channel of a hysteroscope or other delivery device having an outer diameter of 3 mm or less (9F)).
- a delivery device such as the working channel of a hysteroscope or other delivery device having an outer diameter of 3 mm or less (9F)
- the tip can be thermally activated into its austenitic phase using ultrasonic energy (e.g., from about 27 kHz to about 75 kHz).
- the tip In the austenitic phase, the tip has a pre-set bend that serves as the stroke length of the ultrasonic surgical tip, and is subsequently used for denaturization, cauterization, ablation, fractionation, and/or morcellation of leiomyoma or other tissue.
- the surgical tip temperature equilibrates under fluid medium to the martensitic phase, and is retrieved through working channel.
- This device may be used in conjunction with fluid management and aspiration to facilitate the removal of excised, morcellated, and/or fractionated material.
- Another embodiment of the present technology includes a nitinol grasping trap or claw shape that is encapsulated in an insulative coating, thus preventing or substantially preventing thermal transfer to tissue, and constrained into a compressed “grasping” martensitic shape, delivered under fluid medium through the working channel of a cystoscope, ureteroscope, hysteroscope, cannula, catheter, or other lumen, through a narrow or tortuous bodily passage, and into a cavity or space such as within the bladder, kidney, uterus, urethra, ureter, or prostate, and activated (e.g., thermally) into the austenitic phase at transition temperature (around 80° C.) to form a remembered ‘open’ shape that is larger in diameter or different in shape than the inner diameter of the channel or lumen, and is subsequently used to enclose, grasp, and thus capture an object, embolus, tissue or material, and the subsequent removal of energy input causes the claw to cool within the fluid medium to regain a grasp
- Another embodiment of this technology is a nitinol grasping trap or claw shape, encapsulated in an insulative coating thus completely preventing thermal/energy transfer to tissue, and shape set to remember a constricted ‘grasping’ austenitic shape.
- This device is compressed and delivered via the working channel of a cystoscope, ureteroscope, hysteroscope, cannula, catheter, or other lumen, through a narrow or tortuous bodily passage, and into a cavity or space such as within the bladder, kidney, uterus, urethra, ureter, or prostate, and released from constraint to form an ‘open’ martensitic shape, at body or ambient fluid temperature, that is larger in diameter or different in shape than the inner diameter of the channel or lumen.
- the device is then used to enclose, grasp, and thus capture an object or material, and subsequently activated (heated liquid through a lumen or low direct current) into the austenitic phase at transition temperature (around 60° C.) to form the remembered shape and remain in the austenitic ‘grasping shape’ (the force may produce a stronger grasp than embodiment #3) and thus capture an object, embolus, tissue, or material, at which point, while remaining in its austenitic grasping phase, the claw is removed through the lumen along with the retrieved object or material.
- transition temperature around 60° C.
- PtTiNi cutting electrode or probe composed of a single wire or multi wire loop or tube or scoop shape or other shape that can be collapsed into a compressed martensitic shape and delivered through a cannula or catheter or other lumen and then activated into the austenitic phase to resume a pre-formed shape that is larger in diameter than the inner diameter of the channel or lumen, and which is subsequently used to perform cutting, ablation (e.g., super ventricular tachycardia), biopsy, resection, removal, manipulation, and cautery of heart valves, chordae tendinae, cardiac tissue, vascular tissue, other adjacent tissue, or other material.
- ablation e.g., super ventricular tachycardia
- biopsy e.g., resection, removal, manipulation, and cautery of heart valves, chordae tendinae, cardiac tissue, vascular tissue, other adjacent tissue, or other material.
- the electrode or probe temperature Upon removal or reduction of energy input, the electrode or probe temperature equilibrates under fluid medium or ambient tissue temperature to the martensitic phase, and is retrieved through the cannula or catheter or other lumen and may contain a sample of tissue, calcification, atherogenic/atheromatous, fibrous, thrombotic, embolic, or other material or substance. ( FIG. 1 , FIG. 2 , FIG. 3 )
- PtFe cutting electrode or probe composed of a single wire or multi wire loop or tube or scoop shape or other shape that can be collapsed into a compressed martensitic shape and delivered through a cannula or catheter or other lumen and then magnetically activated into the austenitic phase to resume a pre-formed shape that is larger in diameter than the inner diameter of the channel or lumen, and which is subsequently used to perform cutting, ablation, biopsy, removal, manipulation, dissolution, liquification, and cautery, of an atherosclerotic or thrombotic lesion or other unwanted tissue.
- the electrode or probe temperature Upon removal or reduction of energy input, the electrode or probe temperature equilibrates under fluid or ambient blood temperature to the martensitic phase, and is retrieved through the cannula or catheter or other lumen and may contain a sample of tissue, calcification, atherogenic/atheromatous, fibrous, thrombotic, embolic, or other material or substance. ( FIG. 1 , FIG. 2 , FIG. 3 )
- the treatment devices and/or electrodes of the present technology use the shape memory phase (of the SMA that forms the electrode) for or during the treatment or therapeutic functioning of the device unlike many other devices that do not use the shape memory phase (and actually use only the superelastic phase) for or during the actual treatment or therapeutic functioning of the device.
- the treatment device and/or electrode utilizes both the superelastic and shape memory properties of the SMA.
- the treatment devices and/or electrodes of the present technology use the austenite to martensite phase transformation as part of the treatment or therapeutic functioning of the device.
- the treatment device and/or electrode can be compressed to fit through the delivery device lumen or opening in a manner that involves more or significantly more material strain compression than devices that employ superelasticity.
- the treatment devices and/or electrodes of the present technology provide the following advantages over conventional SMA electrodes: ( 1 ) the deployed shapes of the electrodes of the present technology are relatively larger than those of other conventional designs and thus can remove more tissue, ( 2 ) the SMA forming the electrodes of the present technology have an A f temperature that produces a stronger peak force than devices that rely solely on superelasticity.
- Ultrasound, radiofrequency, magnetics, and/or conductive heat can be used to activate the shape memory properties of the electrodes of the present technology.
- the treatment device and/or electrode removes tissue and liquifies the tissue using mechanical (ultrasonic) energy.
- At least a portion of the electrode and/or treatment device includes an SMA that demonstrate superelastic properties but does not revert/reverse to the martensitic phase after being activated in the austenitic phase.
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Plasma & Fusion (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Otolaryngology (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Inorganic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Surgical Instruments (AREA)
Abstract
Medical devices utilizing shape memory alloys and associated methods are disclosed herein. One aspect of the present technology, for example, is directed toward a treatment element configured to be positioned within a body lumen and coupled to an energy source. At least a portion of the treatment element may be made of a shape memory alloy, and wherein application of thermal energy to the treatment element from the energy source transforms the treatment element from the martensitic state to the austenitic state in which the treatment element is configured to cut, ablate, resect, and/or cauterize tissue.
Description
- This application is a continuation of U.S. application Ser. No. 15/488,352, filed Apr. 14, 2017, entitled “MEDICAL DEVICES UTILIZING SHAPE MEMORY ALLOYS AND ASSOCIATED SYSTEMS AND METHOD,” which claims the benefit of U.S. Provisional Application No. 62/322,689, filed Apr. 14, 2016, entitled “MEDICAL DEVICES UTILIZING SHAPE MEMORY ALLOYS AND ASSOCIATED SYSTEMS AND METHOD,” each of which is incorporated by reference herein in its entirety.
- The present technology is directed generally to medical devices utilizing shape memory alloys and associated systems and methods.
- A shape memory alloy (“SMA”) is a metallic alloy that undergoes a phase transformation in its crystal structure when cooled from its stronger, high temperature form (austenite or parent) to its easily deformable, low temperature form (martensite or daughter). This inherent phase transformation is the basis for the unique properties of SMAs, such as shape memory and superelasticity.
- Shape memory refers to the ability of an SMA to go through the following process: (1) While in its martensitic form, the SMA is (easily) deformed to a new shape. (2) Upon being heated through its transformation temperatures, the SMA reverts to austenite and recovers its previous shape (before the deformation) with great force. The temperature at which the SMA remembers its austenite form when heated can be adjusted by slight changes in alloy composition and through heat treatment. Various medical device applications include an SMA component and utilize its shape memory properties to selectively transform the component between two different shapes or configurations. Such SMA components typically have an austenitic phase that is activated at a transition temperature typically at or below body temperature. (Note: body temperature is documented in medical textbooks as 37° C., but it is reported to range between 36.1° C. to 38° C.) Examples of such devices include dental wire, intravascular stents, guidewires, embolic coils, as well as staples, vertebral spacers, intrauterine devices, catheters, cannulas, and minimally invasive surgical instruments.
- Superelasticity is a mechanical version of shape memory, and is caused by the stress-induced formation of some martensite above its normal temperature. Because it has been formed above its normal temperature, the martensite reverts immediately to undeformed austenite as soon as the stress is removed. This process provides a very springy, “rubberlike” elasticity in these alloys. The superelastic properties of SMAs have been employed in various medical device applications where it is advantageous for the device to spring to form. Some examples of such devices include orthodontic wire, venous filters, vascular stents, and minimally invasive surgical instruments.
-
FIG. 1A is a schematic, perspective view of a distal portion of a medical device showing a treatment element in an unconstrained austenitic state in accordance with the present technology. -
FIG. 1B is a schematic, perspective view of the treatment element shown inFIG. 1A bent back on itself in a low-profile martensitic state in a delivery sheath in accordance with the present technology. -
FIG. 1C is a schematic, perspective view of the treatment element shown inFIG. 1A in an elongated low-profile martensitic state in a delivery sheath in accordance with the present technology. -
FIG. 2A is a schematic, perspective view of a distal portion of a medical device showing a treatment element in an unconstrained austenitic state in accordance with the present technology. -
FIG. 2B is a schematic, perspective view of the treatment element shown inFIG. 1A bent back on itself in a low-profile martensitic state in a delivery sheath in accordance with the present technology. -
FIG. 2C is a schematic, perspective view of the treatment element shown inFIG. 1A in an elongated low-profile martensitic state in a delivery sheath in accordance with the present technology. -
FIGS. 3A-3C are side, top, and perspective views, respectively, of a treatment element in accordance with the present technology. -
FIGS. 3D-3F are side, top, and perspective views, respectively, of a treatment element in accordance with the present technology. -
FIGS. 3G-3I are side, top, and perspective views, respectively, of a treatment element in accordance with the present technology. -
FIGS. 3J-3L are side, top, and perspective views, respectively, of a treatment element in accordance with the present technology. -
FIGS. 4A and 4B are schematic illustrations of a treatment element in a deployed state and a constrained state in accordance with the present technology. -
FIG. 5A is a side view of a manipulation member having a looped treatment element at its distal portion in accordance with the present technology. -
FIGS. 5B-5D andFIGS. 6A-6C are side views and perspective side views, respectively, of treatment elements having different angles at their distal portions in the austenitic state in accordance with the present technology. -
FIG. 7A is a side view of a hysteroscopic resectoscope configured for use with the treatment elements of the present technology. -
FIG. 7B is an enlarged view of a distal portion of the hysteroscopic resectoscope shown inFIG. 7A . - The present technology is directed generally to shape memory treatment devices and associated systems and methods. In particular embodiments of the present technology, the treatment device includes a treatment element (e.g., an electrode or other device) configured to be delivered to a treatment site within a body cavity or lumen or other natural body orifice via a delivery device (e.g., a trocar, venipuncture, through a device lumen, etc.). The electrode is made of an SMA and is transformable between a delivery configuration and a deployed configuration via thermal activation. In the delivery configuration, the electrode is in its martensitic form and can be constrained for delivery through a delivery device and/or through narrow or tortuous bodily passages. In the deployed configuration, the electrode is in an austenitic form that is configured to treat, manipulate, or otherwise engage bodily tissue at the treatment site. For example, the shape and/or temperature of the electrode in the austenitic form can be configured for object retrieval, thrombus retrieval, tissue biopsy, tissue manipulation, and/or the atherectomy, morcellation, liquification, denaturation, des sication, fulgaration, cauterization, vaporization, cutting, and/or ablation of target tissue in minimally invasive and surgical applications. The electrode can be thermally activated to its austenitic form at a transition temperature above 40° C. (above body temperature). The electrode is coupled to an energy source, and activation of the austenitic phase of the electrode is achieved through use of heat energy and/or electrical current. Suitable energy sources include, for example, direct current (DC), alternating current (AC), radio frequency (RF), magnetic energy, electromagnetic energy, an electrical current transformed to mechanical energy via an ultrasonic transducer, thermal transfer (via fluidic heat exchange), and others.
- The electrode can be made of an SMA that is selected based on the desired physical characteristics and performance parameters of the particular device. Suitable SMAs include, for example, nickel titanium (“NiTi” or “nitinol”), platinum (“Pt”), platinum-titanium-nickel (“PtTiNi”), platinum iron (“PtFe”), copper-zinc-aluminum (“CuZnAl”), copper-aluminum-nickel (“CuAlNi”), and/or other alloys of/with platinum, nickel, iron, copper, titanium, etc.
- As detailed below, the treatment devices and/or electrodes of the present technology are configured for use in one or more medical applications and/or fields of medicine, such as gynecology, urology, cardiovascular, neurovascular, peripheral vascular, laparoscopy, pulmonology, ENT applications, and gastroenterology. Although the following description pertains to gynecological, urological, cardiovascular, and neurological applications of the present technology, additional medical applications and/or treatment methods are also within the scope of the present technology.
- Modern advances in minimally invasive surgical methods have improved outcomes and reduced complications and recovery times for many types of surgery. In some cases, minimally invasive techniques have made it possible to move surgical procedures out of the operating room and into a doctor's office setting. In the area of women's health, however, minimally invasive advancements are scant, especially as it relates to transcervical hysteroscopic surgery. For example, many hysteroscopic surgical methods today require hysteroscopes having relatively large diameters, e.g., 26 Fr (8 mm), thus necessitating the use of uncomfortable luminaria dilatation, or anesthesia and manual cervical dilation in an operating room setting.
- One embodiment of the present technology configured for gynecological applications includes a cutting electrode having a single or multiple loop configuration during use. At least a portion of the electrode can be formed of an SMA (such as NiTi or PtTiNi). Representative embodiments of the electrode and/or associated systems and methods are shown in
FIGS. 1A-7B . The electrode is configured to be delivered in fluid medium to a uterine cavity through a lumen of a delivery device, such as the working channel of a hysteroscopic resectoscope (FIGS. 7A and 7B ) or other delivery device having a lumen that is 8 mm or less. During delivery to the uterine cavity, the electrode can be compacted into a compressed martensitic shape to fit within the lumen of the delivery device. The electrode can be electrically connected to an energy source. - Once positioned at or near a treatment site (e.g., myoma) within the uterine cavity, the energy source can be electrode can be activated into the austenitic phase to form an expanded, pre-set shape (i.e., wider than the inner diameter of the delivery device lumen). In some embodiments, for example, the electrode can be activated via radiofrequency energy (RF) (e.g., from about 100 kHz to about 5 MHz). When the electrode is in the deployed, pre-set shape, the electrode is configured to perform one or more procedures at the treatment site, such as cutting, ablating, resecting, manipulating, and/or cauterizing tissue such as leiomyoma, endometrium, or other tissue. At any time before, during, and/or after treatment, but before removing the electrode from the uterine cavity, the energy source can be de-activated or otherwise decoupled from the electrode such that the electrode temperature equilibrates (under fluid medium or ambient tissue temperature) to the martensitic phase. Once in the martensitic phase, the device can be withdrawn from the uterine cavity through the delivery device.
- Another embodiment of the present technology configured for gynecological applications is an ultrasonic surgical tip including an SMA (such as NiTi or PtTiNi). Representative embodiments of the electrode and/or associated systems and methods are shown in
FIGS. 1-3 . The tip is configured to be introduced in a straight martensitic form through a lumen of a delivery device (such as the working channel of a hysteroscope or other delivery device having an outer diameter of 3 mm or less (9F)). Once positioned at or near the treatment site in the uterine cavity, the tip can be thermally activated into its austenitic phase using ultrasonic energy (e.g., from about 27 kHz to about 75 kHz). In the austenitic phase, the tip has a pre-set bend that serves as the stroke length of the ultrasonic surgical tip, and is subsequently used for denaturization, cauterization, ablation, fractionation, and/or morcellation of leiomyoma or other tissue. Upon removal of energy input, the surgical tip temperature equilibrates under fluid medium to the martensitic phase, and is retrieved through working channel. This device may be used in conjunction with fluid management and aspiration to facilitate the removal of excised, morcellated, and/or fractionated material. - Another embodiment of the present technology includes a nitinol grasping trap or claw shape that is encapsulated in an insulative coating, thus preventing or substantially preventing thermal transfer to tissue, and constrained into a compressed “grasping” martensitic shape, delivered under fluid medium through the working channel of a cystoscope, ureteroscope, hysteroscope, cannula, catheter, or other lumen, through a narrow or tortuous bodily passage, and into a cavity or space such as within the bladder, kidney, uterus, urethra, ureter, or prostate, and activated (e.g., thermally) into the austenitic phase at transition temperature (around 80° C.) to form a remembered ‘open’ shape that is larger in diameter or different in shape than the inner diameter of the channel or lumen, and is subsequently used to enclose, grasp, and thus capture an object, embolus, tissue or material, and the subsequent removal of energy input causes the claw to cool within the fluid medium to regain a grasping martensitic shape, at which point the claw is removed through the lumen along with the retrieved object or material. (
FIG. 1 ,FIG. 3 ) - Another embodiment of this technology is a nitinol grasping trap or claw shape, encapsulated in an insulative coating thus completely preventing thermal/energy transfer to tissue, and shape set to remember a constricted ‘grasping’ austenitic shape. This device is compressed and delivered via the working channel of a cystoscope, ureteroscope, hysteroscope, cannula, catheter, or other lumen, through a narrow or tortuous bodily passage, and into a cavity or space such as within the bladder, kidney, uterus, urethra, ureter, or prostate, and released from constraint to form an ‘open’ martensitic shape, at body or ambient fluid temperature, that is larger in diameter or different in shape than the inner diameter of the channel or lumen. The device is then used to enclose, grasp, and thus capture an object or material, and subsequently activated (heated liquid through a lumen or low direct current) into the austenitic phase at transition temperature (around 60° C.) to form the remembered shape and remain in the austenitic ‘grasping shape’ (the force may produce a stronger grasp than embodiment #3) and thus capture an object, embolus, tissue, or material, at which point, while remaining in its austenitic grasping phase, the claw is removed through the lumen along with the retrieved object or material. (
FIG. 3 ) - Another embodiment of this technology is a PtTiNi cutting electrode or probe composed of a single wire or multi wire loop or tube or scoop shape or other shape that can be collapsed into a compressed martensitic shape and delivered through a cannula or catheter or other lumen and then activated into the austenitic phase to resume a pre-formed shape that is larger in diameter than the inner diameter of the channel or lumen, and which is subsequently used to perform cutting, ablation (e.g., super ventricular tachycardia), biopsy, resection, removal, manipulation, and cautery of heart valves, chordae tendinae, cardiac tissue, vascular tissue, other adjacent tissue, or other material. Upon removal or reduction of energy input, the electrode or probe temperature equilibrates under fluid medium or ambient tissue temperature to the martensitic phase, and is retrieved through the cannula or catheter or other lumen and may contain a sample of tissue, calcification, atherogenic/atheromatous, fibrous, thrombotic, embolic, or other material or substance. (
FIG. 1 ,FIG. 2 ,FIG. 3 ) - Another embodiment of this technology is a PtFe cutting electrode or probe composed of a single wire or multi wire loop or tube or scoop shape or other shape that can be collapsed into a compressed martensitic shape and delivered through a cannula or catheter or other lumen and then magnetically activated into the austenitic phase to resume a pre-formed shape that is larger in diameter than the inner diameter of the channel or lumen, and which is subsequently used to perform cutting, ablation, biopsy, removal, manipulation, dissolution, liquification, and cautery, of an atherosclerotic or thrombotic lesion or other unwanted tissue. Upon removal or reduction of energy input, the electrode or probe temperature equilibrates under fluid or ambient blood temperature to the martensitic phase, and is retrieved through the cannula or catheter or other lumen and may contain a sample of tissue, calcification, atherogenic/atheromatous, fibrous, thrombotic, embolic, or other material or substance. (
FIG. 1 ,FIG. 2 ,FIG. 3 ) - The treatment devices and/or electrodes of the present technology use the shape memory phase (of the SMA that forms the electrode) for or during the treatment or therapeutic functioning of the device unlike many other devices that do not use the shape memory phase (and actually use only the superelastic phase) for or during the actual treatment or therapeutic functioning of the device.
- In some embodiments, the treatment device and/or electrode utilizes both the superelastic and shape memory properties of the SMA.
- In some embodiments, the treatment devices and/or electrodes of the present technology use the austenite to martensite phase transformation as part of the treatment or therapeutic functioning of the device.
- In some embodiments of the treatment devices and/or electrodes of the present technology, the treatment device and/or electrode can be compressed to fit through the delivery device lumen or opening in a manner that involves more or significantly more material strain compression than devices that employ superelasticity.
- The treatment devices and/or electrodes of the present technology provide the following advantages over conventional SMA electrodes: (1) the deployed shapes of the electrodes of the present technology are relatively larger than those of other conventional designs and thus can remove more tissue, (2) the SMA forming the electrodes of the present technology have an Af temperature that produces a stronger peak force than devices that rely solely on superelasticity.
- Ultrasound, radiofrequency, magnetics, and/or conductive heat can be used to activate the shape memory properties of the electrodes of the present technology.
- In some embodiments of the treatment devices and/or electrodes disclosed herein, the treatment device and/or electrode removes tissue and liquifies the tissue using mechanical (ultrasonic) energy.
- In some embodiments of the treatment devices and/or electrodes disclosed herein, at least a portion of the electrode and/or treatment device includes an SMA that demonstrate superelastic properties but does not revert/reverse to the martensitic phase after being activated in the austenitic phase.
- The following examples are illustrative of several embodiments of the present technology:
-
- 1. A device for removing tissue from a body lumen, the device comprising:
- a delivery shaft having a lumen therethrough;
- an energy source;
- a manipulation member configured to be slidably received through the lumen of the delivery shaft, wherein the manipulation member has a distal portion configured to be positioned within the body lumen; and
- a treatment element at the distal portion of the manipulation member and coupled to the energy source, at least a portion of the treatment element made of a shape memory alloy and having a low-profile martensitic state for delivery through the elongated shaft and an expanded, austenitic state that forms a pre-set shape having a cross-sectional dimension that is greater than the cross-sectional dimension of the shaft, and
- wherein application of thermal energy to the treatment element from the energy source transforms the treatment element from the martensitic state to the austenitic state, and
- wherein, when the treatment element is in the austenitic state, the treatment element is configured to cut, ablate, resect, and/or cauterize tissue.
- 2. The device of example 1, wherein the treatment element transforms from the martensitic state to the austenitic state at a temperature above 40 degrees Celsius.
- 3. The device of example 1 or example 2, wherein the energy source is configured to deliver radiofrequency energy to the treatment element.
- 4. The device of any one of examples 1-3, wherein the treatment element is thermally activated and transforms from the martensitic state at a frequency of from about 100 kHz to about 5 MHz.
- 5. The device of any one of examples 1-4, wherein the distal portion of the manipulation member is configured to be delivered to a uterine cavity.
- 6. The device of example 5, wherein the device is configured to separate a tumor from the uterine cavity.
- 7. The device of any one of examples 1-6, wherein the treatment element has a single loop configuration.
- 8. The device of any one of examples 1-6, wherein the treatment element has a multiple loop configuration.
- 9. The device of any one of example 1-8, wherein the delivery shaft is a portion of a hysteroscopic resectoscope.
- 10. The device of any one of examples 1-9, wherein the delivery shaft includes a fluid medium within the lumen.
- 11. The device of any one of examples 1-10, wherein a cross-sectional dimension of the delivery shaft is no more than 8 mm.
- 12. The device of any one of examples 1-11, wherein the tissue is at least one of a leiomyoma and endometrium.
- 13. A device for removing tissue from a body lumen, the device comprising:
- a delivery shaft having a lumen therethrough;
- an energy source;
- a manipulation member configured to be slidably received through the lumen of the delivery shaft, wherein the manipulation member has a distal portion configured to be positioned within the body lumen; and
- a treatment element at the distal portion of the manipulation member and coupled to the energy source, at least a portion of the electrode made of a shape memory alloy and having a low-profile martensitic state for delivery through the elongated shaft and an expanded, austenitic state that forms a pre-set shape having a cross-sectional dimension that is greater than the cross-sectional dimension of the shaft, and
- wherein application of ultrasonic energy to the treatment element from the energy source transforms the treatment element from the martensitic state to the austenitic state, and
- wherein, when the treatment element is in the austenitic state, the electrode is configured to cut, ablate, resect, morcellate, and/or cauterize tissue comprising at least one of leiomyoma and endometrium.
- 14. The device of example 13, wherein the treatment element transforms from the martensitic state to the austenitic state at a frequency of from about 27 kHz to about 75 kHz.
- 15. The device of example 13 or example 14, wherein the energy source is configured to deliver ultrasonic energy to the treatment element.
- 16. The device of any one of examples 13-15, wherein the treatment element is generally straight in a martensitic state and bent in an austenitic state.
- 17. The device of any one of examples 13-16, wherein the distal portion of the manipulation member is configured to be delivered to a uterine cavity.
- 18. The device of any one of examples 13-17, wherein the device is configured to separate a tumor from the uterine cavity.
- 19. The device of any one of examples 13-18, wherein the treatment element has a single loop configuration.
- 20. The device of any one of examples 13-18, wherein the treatment element has a multiple loop configuration.
- 21. The device of any one of examples 13-20, wherein the delivery shaft is a portion of a hysteroscopic resectoscope.
- 22. The device of any one of examples 13-21, wherein the lumen of the delivery shaft includes a fluid medium.
- 23. The device of any one of examples 13-22, wherein a cross-sectional dimension of the delivery shaft is no more than 3 mm.
- 24. The device of any one of examples 13-23, wherein the tissue is at least one of a leiomyoma and endometrium.
- 25. A method for modifying and/or treating tissue comprising:
- positioning a treatment element in a low-profile martensitic state within a body lumen via a delivery shaft having a cross-sectional dimension, wherein the treatment element is made of a shape memory alloy;
- while the treatment element is positioned within the body lumen, transforming the treatment element from the martensitic state to the austenitic state by delivering thermal energy to the treatment element, wherein, in the austenitic state the treatment element forms an expanded, pre-set shape having a cross-sectional dimension that is greater than the cross-sectional dimension of the delivery shaft; and
- cutting, ablating, resecting, morcellating, and/or cauterizing tissue within the body lumen with the treatment element in the austenitic state.
- 26. The method of example 25, wherein delivering thermal energy includes raising a temperature of the treatment element to no greater than 40 degrees Celsius.
- 27. The method of example 25, wherein the cross-sectional dimension of the delivery shaft is no greater than 8 mm.
- 28. The method of example 25, wherein transforming the treatment element includes delivering a radiofrequency to the treatment element of from about 100 kHz to about 5 MHz.
- 29. A method for modifying and/or treating tissue comprising:
- positioning a treatment element in a low-profile martensitic state within a body lumen via a delivery shaft having a cross-sectional dimension, wherein the treatment element is made of a shape memory alloy;
- while the treatment element is positioned within the body lumen, transforming the treatment element from the martensitic state to the austenitic state by delivering ultrasonic energy to the treatment element, wherein, in the austenitic state the treatment element forms an expanded, pre-set shape having a cross-sectional dimension that is greater than the cross-sectional dimension of the delivery shaft; and
- cutting, ablating, resecting, morcellating, and/or cauterizing tissue within the body lumen with the treatment element in the austenitic state.
- 30. The method of example 29, wherein the cross-sectional dimension of the delivery shaft is no greater than 3 mm.
- 31. The method of example 29, wherein transforming the treatment element includes delivering a ultrasonic energy to the treatment element that has a frequency of from about 27 kHz to about 75 kHz.
- 1. A device for removing tissue from a body lumen, the device comprising:
- From the foregoing, it will be appreciated that specific embodiments of the disclosed technology have been described herein for purposes of illustration, but that various modifications may be made without deviating from the technology. Certain aspects of the technology described in the context of particular embodiments may be combined or eliminated in other embodiments. Further, while advantages associated with certain embodiments of the disclosed technology have been described in the context of those embodiments, other embodiments may also exhibit such advantages, and not all embodiments need necessarily exhibit such advantages to fall within the scope of the technology. Accordingly, the disclosure and associated technology can encompass other embodiments not expressly shown or described herein.
Claims (24)
1. A device for removing tissue from a body lumen, the device comprising:
a delivery shaft having a lumen therethrough;
an energy source;
a manipulation member configured to be slidably received through the lumen of the delivery shaft, wherein the manipulation member has a distal portion configured to be positioned within the body lumen; and
a treatment element at the distal portion of the manipulation member and coupled to the energy source, at least a portion of the treatment element made of a shape memory alloy and having a low-profile martensitic state for delivery through the elongated shaft and an expanded, austenitic state that forms a pre-set shape having a cross-sectional dimension that is greater than the cross-sectional dimension of the shaft, and
wherein application of thermal energy to the treatment element from the energy source transforms the treatment element from the martensitic state to the austenitic state, and
wherein, when the treatment element is in the austenitic state, the treatment element is configured to cut, ablate, resect, and/or cauterize tissue.
2. The device of claim 1 , wherein the treatment element transforms from the martensitic state to the austenitic state at a temperature above 40 degrees Celsius.
3. The device of claim 1 , wherein the energy source is configured to deliver radiofrequency energy to the treatment element.
4. The device of claim 3 , wherein the treatment element is thermally activated and transforms from the martensitic state at a frequency of from about 100 kHz to about 5 MHz.
5. The device of claim 1 , wherein the distal portion of the manipulation member is configured to be delivered to a uterine cavity.
6. The device of claim 5 , wherein the device is configured to separate a tumor from the uterine cavity.
7. The device of claim 1 , wherein the treatment element has a single loop configuration.
8. The device of claim 1 , wherein the treatment element has a multiple loop configuration.
9. The device of claim 1 , wherein the delivery shaft is a portion of a hysteroscopic resectoscope.
10. The device of claim 1 , wherein the lumen of the delivery shaft includes a fluid medium.
11. The device of claim 1 , wherein a cross-sectional dimension of the delivery shaft is no greater than 8 mm.
12. The device of claim 1 , wherein the tissue is at least one of a leiomyoma and endometrium.
13. A device for removing tissue from a body lumen, the device comprising:
a delivery shaft having a lumen therethrough;
an energy source;
a manipulation member configured to be slidably received through the lumen of the delivery shaft, wherein the manipulation member has a distal portion configured to be positioned within the body lumen; and
a treatment element at the distal portion of the manipulation member and coupled to the energy source, at least a portion of the electrode made of a shape memory alloy and having a low-profile martensitic state for delivery through the elongated shaft and an expanded, austenitic state that forms a pre-set shape having a cross-sectional dimension that is greater than the cross-sectional dimension of the shaft, and
wherein application of ultrasonic energy to the treatment element from the energy source transforms the treatment element from the martensitic state to the austenitic state, and
wherein, when the treatment element is in the austenitic state, the electrode is configured to cut, ablate, resect, morcellate, and/or cauterize tissue.
14. The device of claim 13 , wherein the treatment element transforms from the martensitic state to the austenitic state at a frequency of from about 27 kHz to about 75 kHz.
15. The device of claim 13 , wherein the energy source is configured to deliver ultrasonic energy to the treatment element.
16. The device of claim 13 , wherein the treatment element is generally straight in a martensitic state and bent in an austenitic state.
17. The device of claim 13 , wherein the distal portion of the manipulation member is configured to be delivered to a uterine cavity.
18. The device of claim 17 , wherein the device is configured to separate a tumor from the uterine cavity.
19. The device of claim 13 , wherein the treatment element has a single loop configuration.
20. The device of claim 13 , wherein the treatment element has a multiple loop configuration.
21. The device of claim 13 , wherein the delivery shaft is a portion of a hysteroscopic resectoscope.
22. The device of claim 13 , wherein the lumen of the delivery shaft includes a fluid medium.
23. The device of claim 13 , wherein a cross-sectional dimension of the delivery shaft is no greater than 3 mm.
24. The device of claim 13 , wherein the tissue is at least one of a leiomyoma and endometrium.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/650,232 US20220151675A1 (en) | 2016-04-14 | 2022-02-07 | Medical devices utilizing shape memory alloys and associated systems and methods |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662322689P | 2016-04-14 | 2016-04-14 | |
US15/488,352 US11278342B2 (en) | 2016-04-14 | 2017-04-14 | Medical devices utilizing shape memory alloys and associated systems and methods |
US17/650,232 US20220151675A1 (en) | 2016-04-14 | 2022-02-07 | Medical devices utilizing shape memory alloys and associated systems and methods |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/488,352 Continuation US11278342B2 (en) | 2016-04-14 | 2017-04-14 | Medical devices utilizing shape memory alloys and associated systems and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
US20220151675A1 true US20220151675A1 (en) | 2022-05-19 |
Family
ID=60039780
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/488,352 Active 2038-12-16 US11278342B2 (en) | 2016-04-14 | 2017-04-14 | Medical devices utilizing shape memory alloys and associated systems and methods |
US17/650,232 Pending US20220151675A1 (en) | 2016-04-14 | 2022-02-07 | Medical devices utilizing shape memory alloys and associated systems and methods |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/488,352 Active 2038-12-16 US11278342B2 (en) | 2016-04-14 | 2017-04-14 | Medical devices utilizing shape memory alloys and associated systems and methods |
Country Status (4)
Country | Link |
---|---|
US (2) | US11278342B2 (en) |
EP (1) | EP3442457A4 (en) |
CN (1) | CN212261512U (en) |
WO (1) | WO2017181142A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3576667B1 (en) | 2017-01-31 | 2023-12-06 | Swift Health Systems Inc. | Hybrid orthodontic archwires |
WO2023033869A1 (en) * | 2021-09-03 | 2023-03-09 | Swift Health Systems Inc. | Orthodontic appliance with non-sliding archform |
CN115089103B (en) * | 2022-06-27 | 2024-04-05 | 上海宇度医学科技股份有限公司 | Bending system of disposable electric hysteroscope |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5611803A (en) * | 1994-12-22 | 1997-03-18 | Urohealth Systems, Inc. | Tissue segmentation device |
US6645199B1 (en) * | 1999-11-22 | 2003-11-11 | Scimed Life Systems, Inc. | Loop structures for supporting diagnostic and therapeutic elements contact with body tissue and expandable push devices for use with same |
US20130310822A1 (en) * | 2012-05-18 | 2013-11-21 | Holaira, Inc. | Compact delivery pulmonary treatment systems and methods for improving pulmonary function |
US20140276764A1 (en) * | 2013-03-14 | 2014-09-18 | Gyrus ACM, Inc. (d.b.a Olympus Surgical Technologies America) | Flexible RF Ablation Needle |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5190546A (en) | 1983-10-14 | 1993-03-02 | Raychem Corporation | Medical devices incorporating SIM alloy elements |
US5201741A (en) | 1990-07-24 | 1993-04-13 | Andrew Surgical, Inc. | Surgical snare with shape memory effect wire |
US5683366A (en) | 1992-01-07 | 1997-11-04 | Arthrocare Corporation | System and method for electrosurgical tissue canalization |
US6832996B2 (en) | 1995-06-07 | 2004-12-21 | Arthrocare Corporation | Electrosurgical systems and methods for treating tissue |
US5437665A (en) | 1993-10-12 | 1995-08-01 | Munro; Malcolm G. | Electrosurgical loop electrode instrument for laparoscopic surgery |
US6071280A (en) | 1993-11-08 | 2000-06-06 | Rita Medical Systems, Inc. | Multiple electrode ablation apparatus |
US5980517A (en) * | 1995-08-15 | 1999-11-09 | Rita Medical Systems, Inc. | Cell necrosis apparatus |
US5830179A (en) | 1996-04-09 | 1998-11-03 | Endocare, Inc. | Urological stent therapy system and method |
US5980519A (en) | 1996-07-30 | 1999-11-09 | Symbiosis Corporation | Electrocautery probe with variable morphology electrode |
US5749870A (en) | 1996-08-23 | 1998-05-12 | Nebl, Inc. | Electrode for coagulation and resection |
US6375668B1 (en) | 1999-06-02 | 2002-04-23 | Hanson S. Gifford | Devices and methods for treating vascular malformations |
US20020193781A1 (en) | 2001-06-14 | 2002-12-19 | Loeb Marvin P. | Devices for interstitial delivery of thermal energy into tissue and methods of use thereof |
WO2004073524A1 (en) | 2003-02-20 | 2004-09-02 | Manoa Medical, Inc. | Bendable cutting device |
US7182761B2 (en) * | 2003-12-11 | 2007-02-27 | Scimed Life Systems, Inc. | Ablation probe with temperature sensitive electrode array |
US20050228403A1 (en) | 2004-03-31 | 2005-10-13 | Manoa Medical, Inc., A Delaware Corporation | Tissue cutting devices and methods |
US7335197B2 (en) | 2004-10-13 | 2008-02-26 | Medtronic, Inc. | Transurethral needle ablation system with flexible catheter tip |
US7918795B2 (en) * | 2005-02-02 | 2011-04-05 | Gynesonics, Inc. | Method and device for uterine fibroid treatment |
US20070088369A1 (en) | 2005-10-14 | 2007-04-19 | Shaw William J | Snare with loop made of heat shrinkable shape memory material and method of use thereof |
US8790281B2 (en) | 2006-04-20 | 2014-07-29 | The Regents Of The University Of California | Method of thermal treatment of myolysis and destruction of benign uterine tumors |
EP2180839A4 (en) | 2007-08-06 | 2013-08-28 | Michael R Henson | Thrombectomy system and method |
US8157797B2 (en) | 2009-01-12 | 2012-04-17 | Alcon Research, Ltd. | Capsularhexis device with retractable bipolar electrodes |
US8777939B2 (en) | 2010-02-26 | 2014-07-15 | Covidien Lp | Self-tuning microwave ablation probe |
US8518107B2 (en) * | 2010-08-04 | 2013-08-27 | Valcare, Inc. | Percutaneous transcatheter repair of heart valves |
WO2012061159A1 (en) | 2010-10-25 | 2012-05-10 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter apparatuses having multi-electrode arrays for renal neuromodulation and associated systems and methods |
WO2012103157A1 (en) | 2011-01-28 | 2012-08-02 | Medtronc Vascular Inc. | Ablation catheter equipped with a shape memory material |
AU2012347470B2 (en) * | 2011-12-09 | 2017-02-02 | Medtronic Ireland Manufacturing Unlimited Company | Therapeutic neuromodulation of the hepatic system |
EP2968931B1 (en) * | 2013-03-12 | 2022-03-16 | Boston Scientific Scimed, Inc. | Medical systems and methods for modulating nerves |
-
2017
- 2017-04-14 CN CN201790000890.3U patent/CN212261512U/en active Active
- 2017-04-14 US US15/488,352 patent/US11278342B2/en active Active
- 2017-04-14 WO PCT/US2017/027805 patent/WO2017181142A1/en active Application Filing
- 2017-04-14 EP EP17783332.4A patent/EP3442457A4/en active Pending
-
2022
- 2022-02-07 US US17/650,232 patent/US20220151675A1/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5611803A (en) * | 1994-12-22 | 1997-03-18 | Urohealth Systems, Inc. | Tissue segmentation device |
US6645199B1 (en) * | 1999-11-22 | 2003-11-11 | Scimed Life Systems, Inc. | Loop structures for supporting diagnostic and therapeutic elements contact with body tissue and expandable push devices for use with same |
US20130310822A1 (en) * | 2012-05-18 | 2013-11-21 | Holaira, Inc. | Compact delivery pulmonary treatment systems and methods for improving pulmonary function |
US20140276764A1 (en) * | 2013-03-14 | 2014-09-18 | Gyrus ACM, Inc. (d.b.a Olympus Surgical Technologies America) | Flexible RF Ablation Needle |
Also Published As
Publication number | Publication date |
---|---|
EP3442457A4 (en) | 2020-01-01 |
US20170296253A1 (en) | 2017-10-19 |
US11278342B2 (en) | 2022-03-22 |
WO2017181142A1 (en) | 2017-10-19 |
CN212261512U (en) | 2021-01-01 |
EP3442457A1 (en) | 2019-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220151675A1 (en) | Medical devices utilizing shape memory alloys and associated systems and methods | |
JP7053741B2 (en) | Steam cutting system and method | |
US9827008B2 (en) | Snare with loop made of heat shrinkable shape memory material and method of use thereof | |
JP6211576B2 (en) | Recanalization of occluded blood vessels using radio frequency energy | |
AU2016242867B2 (en) | Methods and systems for the manipulation of ovarian tissues | |
JP2020014885A (en) | Methods and systems for treatment of polycystic ovary syndrome | |
AU775490B2 (en) | Method and apparatus for ultrasonic medical treatment, in particular, for debulking the prostate | |
US5906615A (en) | Serpentine ablation/coagulation electrode | |
US8216235B2 (en) | Liquid infusion apparatus for radiofrequency tissue ablation | |
Tan et al. | Holmium laser prostatectomy: current techniques | |
JP2000508207A (en) | Urological stent treatment apparatus and method | |
WO1995005124A1 (en) | Steerable medical probe with stylets | |
JP2005533605A (en) | Apparatus and method for treating urinary incontinence in women | |
GB2311468A (en) | Electrosurgical interstitial resector | |
JP2007522864A (en) | Medical cutting tool with adjustable rotary blade | |
JP2002531204A (en) | Apparatus and method for occluding a uterine artery | |
EP1090658A1 (en) | Ultrasonic medical treatment apparatus | |
JP2022542825A (en) | Genital treatment with pulsed electric fields | |
JP2021516597A (en) | Multi-functional high frequency electric knife | |
Tungjitkusolmun | Ablation | |
Addonnizio et al. | Cavitron ultrasonic surgical aspirator: applications in urologic surgery | |
US20080147046A1 (en) | Catheter having a spirally sliced tube | |
JP7019232B1 (en) | Asymmetric microwave ablation needle with peristaltic function to treat osteosarcoma | |
Shinde et al. | Energy Devices: Working Principles, Uses And Complications | |
Georgescu et al. | Instruments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: APPLICATION UNDERGOING PREEXAM PROCESSING |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |